These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 3093429

  • 1. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T, Sato S, Fujiwara H, Hamaoka T.
    Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
    [Abstract] [Full Text] [Related]

  • 2. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM.
    J Immunol; 1986 Jun 15; 136(12):4674-80. PubMed ID: 3486908
    [Abstract] [Full Text] [Related]

  • 3. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice.
    Maruyama T, Watanabe K, Yanagawa T, Kasatani T, Kasuga A, Shimada A, Takei I, Suzuki Y, Kataoka K, Saruta T.
    Diabetes Res; 1991 Apr 15; 16(4):171-5. PubMed ID: 1802483
    [Abstract] [Full Text] [Related]

  • 4. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T.
    J Immunol; 1984 Sep 15; 133(3):1671-6. PubMed ID: 6205091
    [Abstract] [Full Text] [Related]

  • 5. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 6. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
    Gorelik E.
    Cancer Res; 1987 Feb 01; 47(3):809-15. PubMed ID: 3802083
    [Abstract] [Full Text] [Related]

  • 7. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
    Keller R, Bächi T, Okumura K.
    Exp Cell Biol; 1983 Feb 01; 51(3):158-64. PubMed ID: 6852344
    [Abstract] [Full Text] [Related]

  • 8. Distinct antitumor mechanisms of recombinant interleukin-2 on recombinant interleukin-2-activated killer-sensitive and -resistant murine tumors.
    Maekawa R, Kitagawa T, Koizumi K, Sato K, Homma M.
    J Biol Response Mod; 1989 Dec 01; 8(6):676-90. PubMed ID: 2600605
    [Abstract] [Full Text] [Related]

  • 9. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
    Tomita S, Fujiwara H, Yamane Y, Sano S, Nakajima H, Izumi Y, Arai H, Kawanishi Y, Tsuchida T, Hamaoka T.
    Jpn J Cancer Res; 1986 Feb 01; 77(2):182-9. PubMed ID: 3082830
    [Abstract] [Full Text] [Related]

  • 10. A subset of asialo GM1+ cells play a protective role in the occurrence of graft-versus-host disease in mice.
    De Ruysscher D, Sobis H, Vandeputte M, Waer M.
    J Immunol; 1991 Jun 15; 146(12):4065-70. PubMed ID: 1828259
    [Abstract] [Full Text] [Related]

  • 11. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
    Hinuma S, Naruo K, Ootsu K, Houkan T, Shiho O, Tsukamoto K.
    Immunology; 1987 Feb 15; 60(2):173-9. PubMed ID: 3493209
    [Abstract] [Full Text] [Related]

  • 12. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
    Shibuya M, Saijo N, Ozaki A, Beppu Y, Shimizu E, Takizawa T, Hoshi A.
    Gan To Kagaku Ryoho; 1983 Aug 15; 10(8):1781-6. PubMed ID: 6882003
    [Abstract] [Full Text] [Related]

  • 13. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
    Yang H, Yogeeswaran G, Bukowski JF, Welsh RM.
    Nat Immun Cell Growth Regul; 1985 Aug 15; 4(1):21-39. PubMed ID: 3875791
    [Abstract] [Full Text] [Related]

  • 14. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
    Suzuki S, Suzuki R, Onta T, Kumagai K.
    Nat Immun Cell Growth Regul; 1986 Aug 15; 5(2):75-89. PubMed ID: 3487716
    [Abstract] [Full Text] [Related]

  • 15. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H, Ueda T, Kawahata M, Kobayashi K, Ebihara Y, Manabe A, Tanaka R, Ito M, Asano S, Nakahata T, Tsuji K.
    Bone Marrow Transplant; 2000 Dec 15; 26(11):1211-6. PubMed ID: 11149733
    [Abstract] [Full Text] [Related]

  • 16. Treatment of mice with anti-asialo-GM1 antibody or poly-I:C: effects on metastasis dissociable from modulation of macrophage antitumor activity.
    Riser BL, Laybourn KA, Varani J.
    Nat Immun Cell Growth Regul; 1988 Dec 15; 7(5-6):305-15. PubMed ID: 3221908
    [Abstract] [Full Text] [Related]

  • 17. A glycolipid on the surface of mouse natural killer cells.
    Kasai M, Iwamori M, Nagai Y, Okumura K, Tada T.
    Eur J Immunol; 1980 Mar 15; 10(3):175-80. PubMed ID: 6966574
    [Abstract] [Full Text] [Related]

  • 18. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells.
    Knobloch C, Dennert G.
    J Immunol; 1988 Feb 01; 140(3):744-9. PubMed ID: 2448375
    [Abstract] [Full Text] [Related]

  • 19. In vivo administration of anti-asialo-GM1 antibody enhances splenic clearance of Listeria monocytogenes.
    Schultheis RJ, Kearns RJ.
    Nat Immun Cell Growth Regul; 1990 Feb 01; 9(6):376-86. PubMed ID: 2128370
    [Abstract] [Full Text] [Related]

  • 20. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R, Suzuki S, Ebina N, Kumagai K.
    J Immunol; 1985 Apr 01; 134(4):2139-48. PubMed ID: 2579129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.